Viewing Study NCT06128967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-01-05 @ 1:59 PM
Study NCT ID: NCT06128967
Status: UNKNOWN
Last Update Posted: 2023-11-13
First Post: 2023-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial
Sponsor: Cardresearch
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Long COVID-19 Syndrome View
None Chronic Fatigue Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Long COVID-19 Syndrome View
None Fluvoxamine View
None Metformin View
None Adaptive Trial Design View
None Randomized Controlled Trial View